DD153117A5 - Verfahren zur herstellung von n-phenoxyalkylpiperidin-derivaten - Google Patents

Verfahren zur herstellung von n-phenoxyalkylpiperidin-derivaten Download PDF

Info

Publication number
DD153117A5
DD153117A5 DD80224197A DD22419780A DD153117A5 DD 153117 A5 DD153117 A5 DD 153117A5 DD 80224197 A DD80224197 A DD 80224197A DD 22419780 A DD22419780 A DD 22419780A DD 153117 A5 DD153117 A5 DD 153117A5
Authority
DD
German Democratic Republic
Prior art keywords
group
propoxy
radical
piperidino
benzonitrile
Prior art date
Application number
DD80224197A
Other languages
German (de)
English (en)
Inventor
Walter-Gunar Friebe
Wolfgang Kampe
Max Thiel
Wolfgang Schaumann
Otto-Henning Wilhelms
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of DD153117A5 publication Critical patent/DD153117A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DD80224197A 1979-09-28 1980-09-24 Verfahren zur herstellung von n-phenoxyalkylpiperidin-derivaten DD153117A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792939292 DE2939292A1 (de) 1979-09-28 1979-09-28 N-phenoxyalkylpiperidin-derivate, verfahrenn zu deren herstellung sowie diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
DD153117A5 true DD153117A5 (de) 1981-12-23

Family

ID=6082088

Family Applications (1)

Application Number Title Priority Date Filing Date
DD80224197A DD153117A5 (de) 1979-09-28 1980-09-24 Verfahren zur herstellung von n-phenoxyalkylpiperidin-derivaten

Country Status (10)

Country Link
US (1) US4348401A (fr)
EP (1) EP0026876B1 (fr)
JP (1) JPS5668669A (fr)
AT (1) ATE2519T1 (fr)
CA (1) CA1139759A (fr)
CS (1) CS219950B2 (fr)
DD (1) DD153117A5 (fr)
DE (2) DE2939292A1 (fr)
ES (1) ES8105729A1 (fr)
IL (1) IL61114A0 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996006828A1 (fr) * 1994-08-29 1996-03-07 Richter Gedeon Vegyészeti Gyár Rt. Ethers d'aryle de piperidinoalkyle et compositions pharmaceutiques les contenant

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3209271A1 (de) * 1982-03-13 1983-09-15 Boehringer Mannheim Gmbh, 6800 Mannheim Bicyclische phenolether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
FR2681319B1 (fr) * 1991-09-12 1995-02-17 Synthelabo Derives de 1-(phenoxyalkyl)piperidine, leur preparation et leur application en therapeutique.
GB9319534D0 (en) * 1993-09-22 1993-11-10 Boots Co Plc Therapeutic agents
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610736B (en) 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
ZA9610741B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
MXPA04008795A (es) * 2002-03-13 2004-11-26 Janssen Pharmaceutica Nv Derivados de piperazinilo, piperidinilo y morfolino como novedosos inhibidores de la desacetilasa de histona.
US7767679B2 (en) 2002-03-13 2010-08-03 Janssen Pharmaceutica N.V. Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
EP1485348B1 (fr) * 2002-03-13 2008-06-11 Janssen Pharmaceutica N.V. Derives carbonylamino utilises en tant que nouveaux inhibiteurs d'histone deacetylase
DE60333260D1 (en) * 2002-03-13 2010-08-19 Janssen Pharmaceutica Nv Histone-deacetylase-inhibitoren
PL1781639T3 (pl) 2004-07-28 2012-07-31 Janssen Pharmaceutica Nv Podstawione pochodne indolilo-alkiloaminowe jako nowe inhibitory deacetylazy histonowej
PL1867332T3 (pl) * 2005-04-07 2012-01-31 Toyama Chemical Co Ltd Kompozycja farmaceutyczna i sposób sterowania środka przeciwgrzybiczego w kombinacji
EP1885710B1 (fr) 2005-05-18 2015-08-19 Janssen Pharmaceutica N.V. Dérivés substitués d'aminopropenyl-piperidine ou de morpholine utilisés en tant qu'inhibiteurs de l'histone-désacétylase
AU2007206942B2 (en) 2006-01-19 2012-08-23 Janssen Pharmaceutica N.V. Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
CA2635015C (fr) * 2006-01-19 2014-06-03 Janssen Pharmaceutica N.V. Derive d'indolyl-alkyl-amino substitues en tant qu'inhibiteurs d'histone desacetylase
RS51191B (sr) * 2006-01-19 2010-10-31 Janssen Pharmaceutica N.V. Derivati aminofenila kao novi inhibitori histon deacetilaze
CA2631874C (fr) * 2006-01-19 2014-11-18 Janssen Pharmaceutica N.V. Derives de pyridine et de pyrimidine en tant qu'inhibiteurs d'histone desacetylase
WO2007136790A2 (fr) 2006-05-18 2007-11-29 Mannkind Corporation Inhibiteurs de kinases intracellulaires
KR102077864B1 (ko) 2012-08-01 2020-02-14 쇼와 덴코 패키징 가부시키가이샤 내용물 부착 방지 덮개재

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3255196A (en) * 1966-06-07 Phenoxyalkyl piperidine derivatives
CH411880A (fr) * 1962-02-28 1966-04-30 Rhone Poulenc Sa Procédé de préparation de nouveaux dérivés de la pipéridine
US3691176A (en) * 1970-05-25 1972-09-12 Abbott Lab 1-(4-fluorophenoxypropyl)-4-anilino-piperidines
DE2341376A1 (de) * 1972-08-24 1974-03-07 Ciba Geigy Ag Piperidin-derivate und verfahren zu ihrer herstellung
GB1533383A (en) * 1974-11-15 1978-11-22 Science Union & Cie Arylethers and heterocyclic ethers processes for their preparation and pharmaceutical compositions containing them
US4027028A (en) * 1975-11-10 1977-05-31 Science Union Et Cie Arylethers and pharmaceutical compositions
DE2737630A1 (de) * 1977-08-20 1979-03-01 Boehringer Mannheim Gmbh Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996006828A1 (fr) * 1994-08-29 1996-03-07 Richter Gedeon Vegyészeti Gyár Rt. Ethers d'aryle de piperidinoalkyle et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
ATE2519T1 (de) 1983-03-15
DE2939292A1 (de) 1981-04-09
US4348401A (en) 1982-09-07
DE3062052D1 (en) 1983-03-24
CS219950B2 (en) 1983-03-25
CA1139759A (fr) 1983-01-18
EP0026876B1 (fr) 1983-02-16
ES495412A0 (es) 1981-06-16
IL61114A0 (en) 1980-11-30
EP0026876A1 (fr) 1981-04-15
ES8105729A1 (es) 1981-06-16
JPS5668669A (en) 1981-06-09

Similar Documents

Publication Publication Date Title
DD153117A5 (de) Verfahren zur herstellung von n-phenoxyalkylpiperidin-derivaten
DE2058295C3 (de) Xanthen-9-on-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3336024A1 (de) 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
EP0013894B1 (fr) Aryléthers, procédé pour leur préparation et médicaments les contenant
DE2065636A1 (de) Neue tricyclische verbindungen
DE68917220T2 (de) Phenylpyridon-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen.
DD154364A5 (de) Verfahren zur herstellung von neuen derivaten des piperidylbenzimidazolinons
EP0706522A1 (fr) Derives tetrazoliques a activite antihistaminique et antiallergique
EP1210335B1 (fr) Derives de benzimidazol substitues aminocabonyle, leur procede de preparation et leur utilisation comme produit pharmaceutique
EP0089028B1 (fr) Dérivés de théophylline, et leur procédé de préparation
EP0027908A2 (fr) 2-Hydroxyalkyl-3,4,5-trihydroxy-pipéridines, procédés pour leur préparation et leur utilisation comme médicaments
DE2334009A1 (de) Purin-derivate sowie verfahren zu ihrer herstellung
EP0171645B1 (fr) Dérivés de 2H-1-benzopyran-2-one, procédé pour leur préparation et médicaments les contenant
DE2550000A1 (de) Neue purin-derivate und verfahren zu ihrer herstellung
DE4316117A1 (de) Cycloheptimidazol-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende, therapeutische Mittel
EP0064255A1 (fr) Benzopyranyl éthers, leur procédé de préparation et médicament contenant ces composés et produits intermediaires
DD219642A5 (de) Verfahren zur herstellung von bis-(piperazinyl- bzw. homopiperazinyl)alkanen
EP0021103B1 (fr) Dérivés de théophylline, procédé pour leur préparation et médicaments contenant lesdits composés
DD150001A5 (de) Verfahren zur herstellung einer pyranon-verbindung
DE69005904T2 (de) Phenylpyrimidonderivate.
DE3875030T2 (de) Leukotrien-antagonisten.
EP0003558A1 (fr) 9-(3-Pipéridinopropyl)-purines, procédés pour leur préparation, leur utilisation et compositions pharmaceutiques les contenant
DE2340217C2 (de) 3-Benzoylthiophene, ihre Salze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4427056B4 (de) Neue Carboxymethylidencycloheptimidazol-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als antihypertensive und anticongestive Mittel
DE1929921A1 (de) Neue 1-Alyl-1,2,5,6-tetrahydro-3-pyridylmethyl-carbonsaeureester sowie deren Saeureadditionssalze und quaternaere Ammoniumverbindungen